BFM
ABBV icon

Boothbay Fund Management’s AbbVie ABBV Stock Holding History

Boothbay Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570K Buy
2,265
+1,062
+88% +$228K 0.01% 1411
2026
Q1 		$262K Buy
1,203
+308
+34% +$68.3K ﹤0.01% 1665
2025
Q4 		$204K Sell
895
-3,327
-79% -$758K ﹤0.01% 1652
2025
Q3 		$978K Sell
4,222
-1,697
-29% -$346K 0.01% 847
2025
Q2 		$1.1M Buy
+5,919
New +$1.1M 0.02% 658
2022
Q3 		– Sell
-15,563
Closed -$2.23M – 2194
2022
Q2 		$2.38M Buy
+15,563
New +$2.38M 0.06% 480
2021
Q4 		– Sell
-28,545
Closed -$3.08M – 1811
2021
Q3 		$3.08M Buy
+28,545
New +$3.26M 0.09% 291
2021
Q2 		– Sell
-3,751
Closed -$406K – 1811
2021
Q1 		$406K Sell
3,751
-16,406
-81% -$1.75M 0.02% 1051
2020
Q4 		$2.16M Sell
20,157
-19,204
-49% -$1.85M 0.08% 248
2020
Q3 		$3.45M Buy
39,361
+28,287
+255% +$2.66M 0.21% 105
2020
Q2 		$1.09M Buy
11,074
+3,422
+45% +$301K 0.07% 362
2020
Q1 		$583K Buy
+7,652
New +$652K 0.05% 428
2019
Q4 		– Sell
-14,073
Closed -$1.07M – 825
2019
Q3 		$1.07M Buy
+14,073
New +$965K 0.1% 291
2018
Q4 		– Sell
-4,000
Closed -$378K – 634
2018
Q3 		$378K Sell
4,000
-1,800
-31% -$171K 0.04% 449
2018
Q2 		$537K Sell
5,800
-16,403
-74% -$1.6M 0.05% 333
2018
Q1 		$2.1M Buy
+22,203
New +$2.44M 0.25% 95
2017
Q2 		– Sell
-4,138
Closed -$270K – 648
2017
Q1 		$270K Buy
+4,138
New +$260K 0.05% 470
2016
Q4 		– Sell
-3,781
Closed -$238K – 731
2016
Q3 		$238K Buy
+3,781
New +$245K 0.05% 476

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boothbay Fund Management's ABBV Position: Q2 2026 in Review

Boothbay Fund Management increased its AbbVie (ABBV) stake by 88% in Q2 2026, buying an estimated $228K and bringing the position to 2,265 shares worth $570K. The position accounts for 0.01% of the portfolio, ranked #1411.

Boothbay Fund Management first reported a position in ABBV in Q3 2016 and has held it in 18 quarters since. The position peaked at $3.45M in Q3 2020. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Boothbay Fund Management held 2,265 shares of AbbVie worth $570K as of Q2 2026.
  • Boothbay Fund Management bought 1,062 AbbVie shares in Q2 2026, an estimated $228K.
  • AbbVie made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1411 holding.
  • Boothbay Fund Management first reported a position in AbbVie in Q3 2016 and has held it in 18 quarters since.
  • Boothbay Fund Management's AbbVie position peaked at $3.45M in Q3 2020.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.